MST1 activation by curcumin mediates JNK activation, Foxo3a nuclear translocation and apoptosis in melanoma cells

Teng Yu1, Jiang Ji, Yong-li Guo

  • 1Department of Dermatology, Shandong Ji-ning No. 1 People's Hospital, Shandong Province 272011, PR China.

Insights

Curcumin triggers melanoma cell death by activating mammalian Sterile 20-like kinase 1 (MST1). This pathway involves reactive oxygen species (ROS) and c-Jun N-terminal protein kinase (JNK), leading to apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Curcumin is known to induce apoptosis in melanoma cells.
  • The precise molecular mechanisms underlying curcumin's pro-apoptotic effects in melanoma require further elucidation.
  • The role of mammalian Sterile 20-like kinase 1 (MST1) in this process has not been fully explored.

Purpose of the Study:

  • To investigate the role of mammalian Sterile 20-like kinase 1 (MST1) in curcumin-induced apoptosis of melanoma cells.
  • To determine the involvement of reactive oxygen species (ROS) and c-Jun N-terminal protein kinase (JNK) in this pathway.
  • To explore the downstream targets of MST1 activation by curcumin.

Main Methods:

  • Melanoma cell culture and treatment with curcumin.
  • MST1 silencing using RNA interference (RNAi).
  • Assessment of apoptosis, ROS production (using N-acetyl-cysteine (NAC) as a scavenger), MST1 activation, JNK activation, Foxo3 nuclear translocation, and Bim-1 expression.

Main Results:

  • Curcumin activated MST1, leading to apoptosis in melanoma cells.
  • MST1 silencing reduced curcumin-induced apoptosis, while MST1 overexpression enhanced sensitivity.
  • Curcumin-induced ROS production was essential for MST1 activation.
  • JNK activation, Foxo3 nuclear translocation, and Bim-1 expression were dependent on MST1 activation by curcumin.

Conclusions:

  • MST1 activation is a key mediator of curcumin-induced apoptosis in melanoma cells.
  • The pathway involves ROS generation, MST1 activation, subsequent JNK activation, and Foxo3a nuclear translocation, ultimately promoting apoptosis.
  • These findings highlight MST1 as a potential therapeutic target in melanoma treatment.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K